Hepatocellular carcinoma (HCC) is a major global health issue, with significant morbidity and mortality rates. As the sixth most common cancer and the third leading cause of cancer-related deaths, HCC ...

As many as 40% of lumpectomies leave positive margins that necessitate a second surgery, but a novel fluorescent imaging agent used along with a direct visualization system may improve complete ...

Successful surgery for head and neck squamous cell carcinoma (HNSCC) relies upon complete tumor removal and safe preservation of the fragile nerves in the vicinity. Both are challenging. Fluorescence ...

A research group from Nagoya University has successfully developed a surgical training model using konjac, a processed jelly made from the bulb of the konjac plant. Konjac is commonly used as an ...

Boston-based Mass General Cancer Center used fluorescent agent technology during breast cancer surgery to remove residual tumor cells and possibly prevent the need for secondary surgery. The study, ...

Accurate removal of tumors is the most critical aspect of cancer surgery, yet it remains a significant challenge in clinical practice. In breast cancer, for example, the positive margin rate—where ...

Getinge AB is acquiring 100% of the equity in fluorescence imaging company Fluoptics SAS, a company using the technology as an aid to surgery. Getinge will, through its subsidiary Getinge Infection ...

A high-level live operative surgical workshop titled “Illuminating Precision: Advances in Fluorescence-Guided Surgery” threw light on the evolving role of Fluorescence-Guided Surgery (FGS) in the ...

Light-guided cancer surgery has been in development for some time with varying degrees of success, from light therapy to glow-in-the-dark tumors and the development of compounds that can illuminate ...

A nerve-illuminating agent to minimize surgical risk passed an early test by achieving sustained fluorescence of the obturator nerve without safety concerns in patients undergoing robotic-assisted ...